LCS Total Knee System
Depuy, Inc. · Decision date Jul 15, 2026
What did the FDA decide?
FDA records P830055/S368 as a supplement to PMA P830055, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 15, 2026.
FDA approval order statement
additional packaging sealers for manufacturing Attune Knee system Femoral CR and PS and Attune Patella Medialized Dome Cemented components at the Suzhou, China facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Jul 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P830055/S368
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy, Inc.
- Product code
- NJL
- Decision code
- OK30
- Decision date
- Jul 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Depuy, Inc.
- Product code
- NJL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P830055/S341 · Related supplement
LCS(R) TOTAL KNEE SYSTEM
P830055/S347 · Related supplement
LCS Total Knee System
P830055/S348 · Related supplement
LCS Total Knee System
P830055/S349 · Related supplement
LCS Total Knee System
P830055/S350 · Related supplement
LCS Total Knee System
P830055/S352 · Related supplement
LCS Total Knee System
P830055/S353 · Related supplement
LCS Total Knee System
P830055/S354 · Related supplement
LCS Total Knee System
P830055/S355 · Related supplement
LCS Total Knee System
P830055/S346 · Related supplement
ATTUNE Revision Rotating Platform (RP) Knee System
P830055/S356 · Related supplement
LCS Total Knee System
P830055/S359 · Related supplement
LCS Total Knee System
P830055/S357 · Related supplement
LCS Total Knee System
P830055/S358 · Related supplement
LCS Total Knee System
P830055/S361 · Related supplement
LCS Total Knee System
P830055/S363 · Related supplement
LCS Total Knee System
P830055/S362 · Related supplement
LCS Total Knee System
P830055/S366 · Related supplement
LCS Total Knee System
P830055/S367 · Related supplement
LCS Total Knee System
P830055/S368 received
Application receipt date recorded by FDA.
P830055/S368 · FDA decision
30-Day Notice
P830055/S360 · Related supplement
ATTUNE Revision Knee System
P830055/S370 · Related supplement
LCS(R) TOTAL KNEE SYSTEM
P830055/S369 · Related supplement
LCS Total Knee System- ATTUNE Revision Rotating Platform Knee System
P830055/S371 · Related supplement
LCS Total Knee System
P830055/S373 · Related supplement
LCS Total Knee System
P830055/S374 · Related supplement
LCS(R) TOTAL KNEE SYSTEM, specifically ATTUNE Cruciate Retaining (CR), Posterior Stabilized (PS) and Revision Femoral C
P830055/S372 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, ATTUNE Revision R
P830055/S376 · Related supplement
Attune Rotating Platform (RP) Total Knee System and the DePuy P.F.C. Sigma Rotating Platform (RP) Total Knee System an
P830055/S351 · Related supplement
Attune Revision Knee System
P830055/S375 · Related supplement
LCS Total Knee System
P830055/S380 · Related supplement
LCS Total Knee System
P830055/S377 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Revision Rotating Platform (RP) Total Knee System, and M.B.T. Re
P830055/S379 · Related supplement
ATTUNE Revision Knee System
P830055/S378 · Related supplement
LCS Knee System
P830055/S381 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System
Timeline entries are records held by MedtechLedger for P830055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P830055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LCS(R) TOTAL KNEE SYSTEMP830055/S341 | Depuy, Inc. | PMA supplement | Jul 18, 2025 | FDA |
LCS Total Knee SystemP830055/S347 | Depuy, Inc. | PMA supplement | Aug 5, 2025 | FDA |
LCS Total Knee SystemP830055/S348 | Depuy, Inc. | PMA supplement | Aug 29, 2025 | FDA |
LCS Total Knee SystemP830055/S349 | Depuy, Inc. | PMA supplement | Sep 9, 2025 | FDA |
LCS Total Knee SystemP830055/S350 | Depuy, Inc. | PMA supplement | Sep 26, 2025 | FDA |
LCS Total Knee SystemP830055/S352 | Depuy, Inc. | PMA supplement | Nov 26, 2025 | FDA |
LCS Total Knee SystemP830055/S353 | Depuy, Inc. | PMA supplement | Dec 9, 2025 | FDA |
LCS Total Knee SystemP830055/S354 | Depuy, Inc. | PMA supplement | Dec 11, 2025 | FDA |
LCS Total Knee SystemP830055/S355 | Depuy, Inc. | PMA supplement | Dec 15, 2025 | FDA |
| Depuy, Inc. | PMA supplement | Dec 18, 2025 | FDA | |
LCS Total Knee SystemP830055/S356 | Depuy, Inc. | PMA supplement | Jan 16, 2026 | FDA |
LCS Total Knee SystemP830055/S359 | Depuy, Inc. | PMA supplement | Jan 30, 2026 | FDA |
LCS Total Knee SystemP830055/S357 | Depuy, Inc. | PMA supplement | Feb 12, 2026 | FDA |
LCS Total Knee SystemP830055/S358 | Depuy, Inc. | PMA supplement | Feb 13, 2026 | FDA |
LCS Total Knee SystemP830055/S361 | Depuy, Inc. | PMA supplement | Feb 13, 2026 | FDA |
LCS Total Knee SystemP830055/S363 | Depuy, Inc. | PMA supplement | Mar 27, 2026 | FDA |
LCS Total Knee SystemP830055/S362 | Depuy, Inc. | PMA supplement | Apr 10, 2026 | FDA |
LCS Total Knee SystemP830055/S366 | Depuy, Inc. | PMA supplement | Jun 3, 2026 | FDA |
LCS Total Knee SystemP830055/S367 | Depuy, Inc. | PMA supplement | Jun 29, 2026 | FDA |
ATTUNE Revision Knee SystemP830055/S360 | Depuy, Inc. | PMA supplement | Aug 5, 2026 | FDA |
LCS(R) TOTAL KNEE SYSTEMP830055/S370 | Depuy, Inc. | PMA supplement | Aug 19, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Aug 21, 2026 | FDA | |
LCS Total Knee SystemP830055/S371 | Depuy, Inc. | PMA supplement | Aug 21, 2026 | FDA |
LCS Total Knee SystemP830055/S373 | Depuy, Inc. | PMA supplement | Aug 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 9, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 10, 2026 | FDA | |
Attune Revision Knee SystemP830055/S351 | Depuy, Inc. | PMA supplement | Sep 21, 2026 | FDA |
LCS Total Knee SystemP830055/S375 | Depuy, Inc. | PMA supplement | Sep 25, 2026 | FDA |
LCS Total Knee SystemP830055/S380 | Depuy, Inc. | PMA supplement | Oct 5, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
| Zimmer, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 988, 700 Orthopaedic Dr., Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P830055/S368
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






